Skip to main content
. 2020 Jan 31;10:1664. doi: 10.3389/fphar.2019.01664

Figure 1.

Figure 1

Regulatory frameworks for on- and off-label use of new therapeutic indications in Europe. Marketing authorization (MA), well-established use (WEU), commission regulation (Reg).